公开(公告)号：US07214681B2

公开(公告)日：2007-05-08

申请号：US10776584

申请日：2004-02-10

Applicant: Matthew Colin Thor Fyfe ,  Lisa Sarah Gardner ,  Maseo Nawano ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Karen Lesley Schofield ,  Vilasben Kanji Shah ,  Kosuke Yasuda

Inventor： Matthew Colin Thor Fyfe ,  Lisa Sarah Gardner ,  Maseo Nawano ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Karen Lesley Schofield ,  Vilasben Kanji Shah ,  Kosuke Yasuda

IPC: A61K31/502 ,  C07D43/02

CPC classification number: C07D231/12 ,  C07D211/34 ,  C07D213/55 ,  C07D233/56 ,  C07D249/08 ,  C07D277/30 ,  C07D277/40 ,  C07D277/46 ,  C07D307/54 ,  C07D309/04 ,  C07D309/08 ,  C07D333/24 ,  C07D333/28 ,  C07D335/02 ,  C07D405/10 ,  C07D405/12 ,  C07D407/12 ,  C07D409/10 ,  C07D413/12 ,  C07D417/12 ,  C07D417/14 ,  C07D491/08

Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Abstract translation: 式（I）化合物或其药学上可接受的盐可用于预防和治疗高血糖症和糖尿病。

公开(公告)号：US07074933B2

公开(公告)日：2006-07-11

申请号：US10775464

申请日：2004-02-10

Applicant: Daniel Y. Du ,  Martin James Procter ,  Matthew Colin Thor Fyfe ,  Vilasben Kanji Shah ,  Geoffrey Martyn Williams ,  Karen Lesley Schofield

Inventor： Daniel Y. Du ,  Martin James Procter ,  Matthew Colin Thor Fyfe ,  Vilasben Kanji Shah ,  Geoffrey Martyn Williams ,  Karen Lesley Schofield

IPC: C07D215/38 ,  C07D311/02 ,  A61K31/47

CPC classification number: C07D405/12 ,  C07D215/38 ,  C07D311/14 ,  C07D407/12

Abstract: The invention is directed to a new class of quinolin-zene and z-exc chromen compounds that have been derivatized at the 6-position with a urea or this urea moet, and to then use as androgen antagonists.

Abstract translation: 本发明涉及一种新的喹啉和z-激音色素化合物，它们已经在尿素或这种尿素环上在6位被衍生化，然后用作雄激素拮抗剂。

公开(公告)号：US07064207B2

公开(公告)日：2006-06-20

申请号：US10758582

申请日：2004-01-15

Applicant: Daniel Y. Du ,  Matthew Colin Thor Fyfe ,  Martin James Procter ,  Karen Lesley Schofield ,  Vilasben Kanji Shah ,  Geoffrey Martyn Williams

Inventor： Daniel Y. Du ,  Matthew Colin Thor Fyfe ,  Martin James Procter ,  Karen Lesley Schofield ,  Vilasben Kanji Shah ,  Geoffrey Martyn Williams

IPC: C07D215/16 ,  C07D311/04

CPC classification number: C07D215/36 ,  C07D215/227 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D409/14 ,  C07D413/12 ,  C07D417/12 ,  C07D491/08 ,  C07D491/10

Abstract: The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.

Abstract translation: 本发明涉及一类新的6-亚磺酰氨基 - 喹啉-2-酮和6-亚磺酰氨基-2-氧代 - 色烯衍生物，用于雄激素拮抗剂，并减轻与雄激素受体不适当激活相关的病症。

公开(公告)号：US08207147B2

公开(公告)日：2012-06-26

申请号：US10584025

申请日：2004-12-23

Applicant: Matthew Colin Thor Fyfe ,  Lisa Sarah Gardner ,  John King-Underwood ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Karen Lesley Schofield ,  Gerard Hugh Thomas

Inventor： Matthew Colin Thor Fyfe ,  Lisa Sarah Gardner ,  John King-Underwood ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Karen Lesley Schofield ,  Gerard Hugh Thomas

IPC: A61K31/66 ,  A61K31/497 ,  A61K31/4523 ,  C07D401/14 ,  C07F9/02 ,  C07D211/00 ,  C07D413/14

CPC classification number: C07D413/14 ,  C07D401/14 ,  C07D413/04 ,  C07D413/06 ,  C07D417/04 ,  C07D417/14

Abstract: Compounds of Formula (I), R1-A-V—B—R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.

Abstract translation: 式（I）的化合物，R1-A-V-B-R2; 或其药学上可接受的盐是GPR116的激动剂，并且可用作饱腹感的调节剂，例如， 用于治疗肥胖症和治疗糖尿病。

公开(公告)号：US20110212939A1

公开(公告)日：2011-09-01

申请号：US13003571

申请日：2009-07-10

Applicant: Lisa Sarah Bertram ,  Philip Graham Clarke ,  Graham John Dawson ,  Peter Timothy Fry ,  Matthew Colin Thor Fyfe ,  William Gattrell ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Thomas Martin Krulle ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Colin Peter Sambrook-Smith ,  Simon Andrew Swain

Inventor： Lisa Sarah Bertram ,  Philip Graham Clarke ,  Graham John Dawson ,  Peter Timothy Fry ,  Matthew Colin Thor Fyfe ,  William Gattrell ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Thomas Martin Krulle ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Colin Peter Sambrook-Smith ,  Simon Andrew Swain

IPC: A61K31/397 ,  C07D401/04 ,  A61K31/506 ,  C07D401/14 ,  A61K31/4965 ,  A61K31/454 ,  A61K31/4725 ,  A61K31/4709 ,  A61K31/517 ,  A61P3/00

CPC classification number: C07D401/12 ,  C07D295/205 ,  C07D401/04 ,  C07D401/14 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/14

Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPCR（GPR119）激动剂，可用于治疗糖尿病和肥胖症。

公开(公告)号：US20110195994A1

公开(公告)日：2011-08-11

申请号：US13003569

申请日：2009-07-10

Applicant: Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe

Inventor： Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe

IPC: A61K31/454 ,  C07D401/04 ,  A61P3/00 ,  A61P9/12

CPC classification number: C07D413/04

Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPCR激动剂，可用于治疗糖尿病和肥胖症。

公开(公告)号：US20100022591A1

公开(公告)日：2010-01-28

申请号：US12522018

申请日：2008-01-04

Applicant: Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Simon Andrew Swain

Inventor： Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Simon Andrew Swain

IPC: A61K31/454 ,  C07D401/04 ,  A61P3/10 ,  A61P9/10 ,  A61P3/04

CPC classification number: C07D413/04

Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPCR激动剂，可用于治疗肥胖症和糖尿病。

公开(公告)号：US20090221824A1

公开(公告)日：2009-09-03

申请号：US11573471

申请日：2005-08-12

Applicant: Paul Howard Briner ,  Matthew Colin Thor Fyfe ,  John Paul Madeley ,  Peter John Murray ,  Martin James Procter ,  Felix Spindler

Inventor： Paul Howard Briner ,  Matthew Colin Thor Fyfe ,  John Paul Madeley ,  Peter John Murray ,  Martin James Procter ,  Felix Spindler

IPC: C07D405/12 ,  C07D315/00 ,  C07D417/12

CPC classification number: C07D405/12 ,  C07D309/04 ,  C07D417/12

Abstract: A process for the production of compounds comprising the enantioselective hydrogenation of 2-substituted acrylic acid derivatives.

Abstract translation: 一种制备包含2-取代的丙烯酸衍生物的对映选择性氢化的化合物的方法。

公开(公告)号：US20090221639A1

公开(公告)日：2009-09-03

申请号：US12225961

申请日：2007-04-05

Applicant: Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe ,  Martin James Procter ,  Geoffrey Martyn Williams

Inventor： Lisa Sarah Bertram ,  Matthew Colin Thor Fyfe ,  Martin James Procter ,  Geoffrey Martyn Williams

IPC: A61K31/4545 ,  C07D413/02 ,  A61K31/454 ,  C07D401/02 ,  A61P3/04 ,  A61P3/10 ,  A61P3/00

CPC classification number: C07D413/14 ,  C07D413/12

Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPR119的激动剂，可用作饱腹感调节剂，例如， 用于治疗肥胖症和治疗糖尿病。

公开(公告)号：US20090203676A1

公开(公告)日：2009-08-13

申请号：US11922826

申请日：2006-06-30

Applicant: Oscar Barba ,  Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Lisa Sarah Bertram ,  William Gattrell ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Simon Andrew Swain

Inventor： Oscar Barba ,  Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Lisa Sarah Bertram ,  William Gattrell ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Simon Andrew Swain

IPC: A61K31/496 ,  C07D401/06 ,  C07D401/14 ,  C07D413/14 ,  C07D497/08 ,  A61K31/551 ,  A61K31/454 ,  A61P3/04 ,  A61P3/10 ,  A61P3/00

CPC classification number: C07D401/04 ,  C07D211/20 ,  C07D211/26 ,  C07D401/06 ,  C07D401/12 ,  C07D405/12 ,  C07D413/12 ,  C07D487/08

Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPCR激动剂，可用于治疗肥胖症和糖尿病。